產(chǎn)品展示
艾美捷抗人IL-2單克隆抗體MT2A91/2C95化學(xué)性質(zhì)&文獻(xiàn)參考
點(diǎn)擊次數(shù):0發(fā)布時間:2022/9/27 17:36:05
更新日期:2022/9/27 17:36:05
所 在 地:中國大陸
產(chǎn)品型號:
優(yōu)質(zhì)供應(yīng)
詳細(xì)內(nèi)容
推薦 MT2A91/2C95 作為 ELISA 和 ELISpot 中的捕獲抗體與生物素化檢測抗體 MT8G10 結(jié)合使用。相關(guān)研究如下:
3445-1HP-2 ELISA Pro:人 IL-2 2 板
3445M-1HP-2 ELISA Pro:猴子 IL-2 2 板
艾美捷抗人IL-2單克隆抗體MT2A91/2C95配套研究:
3310-10-1000 ELISpot 偶聯(lián)物:鏈霉親和素-ALP 1 ml
3310-8-1000 ELISA 偶聯(lián)物:鏈霉親和素-ALP 1 ml
3310-9-1000 ELISA/ELISpot 偶聯(lián)物:Streptavidin-HRP 1 ml
3445-6-1000 抗人 IL-2 mAb (MT8G10),生物素 1 mg
艾美捷抗人IL-2單克隆抗體MT2A91/2C95化學(xué)性質(zhì):
應(yīng)用:酶聯(lián)免疫吸附試驗(yàn)/酶標(biāo)儀
反應(yīng)性:人類 / NHP
特異性:天然和重組 IL-2
同種型:小鼠 IgG2b/IgG1
內(nèi)容:MT2A91/2C95,純化,含 0.02% 疊丨氮化鈉的 PBS 溶液,濃度為 0.5 mg/ml
尺寸:1毫克
艾美捷抗人IL-2單克隆抗體MT2A91/2C95參考文獻(xiàn):
Ashrafi, S., et al. (2016). Immunological consequences of immunization with tumor lysate vaccine and propranolol as an adjuvant: A study on cytokine profiles in breast tumor microenvironment. Immunology letters.
Höglind, A., et al. (2016). Systematic Evaluation of Monoclonal Antibodies and Immunoassays for the Detection of Interferon-γ and Interleukin-2 in Old and New World Non-Human Primates. Journal of immunological methods.
Mazor, R., et al. (2017). Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epies in PE38. Cellular immunology.
Song, P., et al. (2018). Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection. Nat Commun.
Starc, N., et al. (2017). Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome. Cytotherapy.